CB4Cancer

CB4Cancer enables early detection of blood cancer, otherwise difficult to diagnose in early stage, saving lives while reducing the medical treatment cost

  • Stage Product In Development
  • Industry Biotechnology
  • Location New Haven, CT, USA
  • Currency USD
  • Founded December 2023
  • Employees 5
  • Incorporation Type LLC

Company Summary

CB4Cancer developed the only predictive AI test-less solution that relies solely on an existing standard and routine low cost tests to predict the development of cancer to enable early detection and early treatment.

CB4Cancer is charging a nominal fee for every blood test is analyzes. Coupled with significant medical treatment cost savings it provides healthcare payors with a 14X ROI.

Team

Previous Investors

  • Precipio
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free